Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Adagene logo

Adagene

Recent Finacing

Series D

Recent Raise

$69M

Adagene is a Suzhou-based antibody discovery and development company using its Dynamic Precision Library platform to engineer mono- and bispecific agonist and antagonist therapeutics and partner for clinical development.

Founded 2011
Jiangsu, China
51-100
Publicly Traded
adagene.com

Highlights

Focus Areas

Biotechnology
Medical
Oncology
Therapeutics

Recent Investors

New World TMT logo
F-Prime Capital logo
General Atlantic logo
AVIC Trust logo
K
Hongshan Capital Group (Sequoia Capital China) logo
Gopher Asset Management logo
WuXi AppTec logo
GP Capital logo
Eight Roads Ventures logo
WuXi Venture logo
Fidelity Management & Research Company logo

Financials

$155M

Total Raised

4

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at Adagene.